Advertisement

Index by author

August 01, 2015; Volume 43,Issue 8

A

  1. Aftab, Dana

    1. Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites
      Steven Lacy, Bih Hsu, Dale Miles, Dana Aftab, Ronghua Wang and Linh Nguyen
      Drug Metabolism and Disposition August 2015, 43 (8) 1190-1207; DOI: https://doi.org/10.1124/dmd.115.063610

  2. Aklillu, Eleni

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  3. Althurwi, Hassan N.

    1. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol
      Hassan N. Althurwi, Zaid H. Maayah, Osama H. Elshenawy and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition August 2015, 43 (8) 1254-1266; DOI: https://doi.org/10.1124/dmd.115.063776

B

  1. Bradbury, J. Alyce

    1. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
      Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
      Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139

C

  1. Cai, Jian-Ping

    1. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59
      Da-Peng Dai, Shuang-Hu Wang, Chuan-Bao Li, Pei-Wu Geng, Jie Cai, Hao Wang, Guo-Xin Hu and Jian-Ping Cai
      Drug Metabolism and Disposition August 2015, 43 (8) 1246-1249; DOI: https://doi.org/10.1124/dmd.115.063412

  2. Cai, Jie

    1. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59
      Da-Peng Dai, Shuang-Hu Wang, Chuan-Bao Li, Pei-Wu Geng, Jie Cai, Hao Wang, Guo-Xin Hu and Jian-Ping Cai
      Drug Metabolism and Disposition August 2015, 43 (8) 1246-1249; DOI: https://doi.org/10.1124/dmd.115.063412

  3. Calamia, Justina C.

    1. Variability in Expression of CYP3A5 in Human Fetal Liver
      Carrie A. Vyhlidal, Robin E. Pearce, Roger Gaedigk, Justina C. Calamia, Diana L. Shuster, Kenneth E. Thummel and J. Steven Leeder
      Drug Metabolism and Disposition August 2015, 43 (8) 1286-1293; DOI: https://doi.org/10.1124/dmd.115.064998

  4. Cao, Lijuan

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  5. Chaudhry, Amarjit S.

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  6. Cheng, Xuefang

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

D

  1. Dai, Da-Peng

    1. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59
      Da-Peng Dai, Shuang-Hu Wang, Chuan-Bao Li, Pei-Wu Geng, Jie Cai, Hao Wang, Guo-Xin Hu and Jian-Ping Cai
      Drug Metabolism and Disposition August 2015, 43 (8) 1246-1249; DOI: https://doi.org/10.1124/dmd.115.063412

  2. DeGraff, Laura M.

    1. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
      Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
      Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139

E

  1. Edin, Matthew L.

    1. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
      Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
      Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139

  2. El-Kadi, Ayman O. S.

    1. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol
      Hassan N. Althurwi, Zaid H. Maayah, Osama H. Elshenawy and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition August 2015, 43 (8) 1254-1266; DOI: https://doi.org/10.1124/dmd.115.063776

  3. Elshenawy, Osama H.

    1. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol
      Hassan N. Althurwi, Zaid H. Maayah, Osama H. Elshenawy and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition August 2015, 43 (8) 1254-1266; DOI: https://doi.org/10.1124/dmd.115.063776

F

  1. Fan, Yiping

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  2. Finkelstein, David

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  3. Fohner, Alison

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  4. Foti, Robert S.

    1. “Target-Site” Drug Metabolism and Transport
      Robert S. Foti, Rachel F. Tyndale, Kristine L. P. Garcia, Douglas H. Sweet, Swati Nagar, Satish Sharan and Dan A. Rock
      Drug Metabolism and Disposition August 2015, 43 (8) 1156-1168; DOI: https://doi.org/10.1124/dmd.115.064576

  5. Franklin, Rebekah K.

    1. A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection
      Rebekah K. Franklin, Sarah A. Marcus, Adel M. Talaat, Butch K. KuKanich, Ruth Sullivan, Lisa A. Krugner-Higby and Timothy D. Heath
      Drug Metabolism and Disposition August 2015, 43 (8) 1236-1245; DOI: https://doi.org/10.1124/dmd.115.063602

  6. Fukami, Tatsuki

    1. Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem Deacetylase
      Takaya Kurokawa, Tatsuki Fukami and Miki Nakajima
      Drug Metabolism and Disposition August 2015, 43 (8) 1218-1225; DOI: https://doi.org/10.1124/dmd.115.064089

G

  1. Gaedigk, Roger

    1. Variability in Expression of CYP3A5 in Human Fetal Liver
      Carrie A. Vyhlidal, Robin E. Pearce, Roger Gaedigk, Justina C. Calamia, Diana L. Shuster, Kenneth E. Thummel and J. Steven Leeder
      Drug Metabolism and Disposition August 2015, 43 (8) 1286-1293; DOI: https://doi.org/10.1124/dmd.115.064998

  2. Garcia, Kristine L. P.

    1. “Target-Site” Drug Metabolism and Transport
      Robert S. Foti, Rachel F. Tyndale, Kristine L. P. Garcia, Douglas H. Sweet, Swati Nagar, Satish Sharan and Dan A. Rock
      Drug Metabolism and Disposition August 2015, 43 (8) 1156-1168; DOI: https://doi.org/10.1124/dmd.115.064576

  3. Geng, Pei-Wu

    1. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59
      Da-Peng Dai, Shuang-Hu Wang, Chuan-Bao Li, Pei-Wu Geng, Jie Cai, Hao Wang, Guo-Xin Hu and Jian-Ping Cai
      Drug Metabolism and Disposition August 2015, 43 (8) 1246-1249; DOI: https://doi.org/10.1124/dmd.115.063412

  4. Graves, Joan P.

    1. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
      Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
      Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139

  5. Gruzdev, Artiom

    1. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
      Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
      Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139

H

  1. Hamamura, Satoko

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  2. Hao, Haiping

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  3. Heath, Timothy D.

    1. A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection
      Rebekah K. Franklin, Sarah A. Marcus, Adel M. Talaat, Butch K. KuKanich, Ruth Sullivan, Lisa A. Krugner-Higby and Timothy D. Heath
      Drug Metabolism and Disposition August 2015, 43 (8) 1236-1245; DOI: https://doi.org/10.1124/dmd.115.063602

  4. Hirao, Yukihiro

    1. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo
      Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.115.064527

  5. Hoopes, Samantha L.

    1. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
      Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
      Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139

  6. House, John S.

    1. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
      Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
      Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139

  7. Hsu, Bih

    1. Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites
      Steven Lacy, Bih Hsu, Dale Miles, Dana Aftab, Ronghua Wang and Linh Nguyen
      Drug Metabolism and Disposition August 2015, 43 (8) 1190-1207; DOI: https://doi.org/10.1124/dmd.115.063610

  8. Hu, Guo-Xin

    1. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59
      Da-Peng Dai, Shuang-Hu Wang, Chuan-Bao Li, Pei-Wu Geng, Jie Cai, Hao Wang, Guo-Xin Hu and Jian-Ping Cai
      Drug Metabolism and Disposition August 2015, 43 (8) 1246-1249; DOI: https://doi.org/10.1124/dmd.115.063412

K

  1. Kamimura, Hidetaka

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  2. Kato, Kota

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  3. Kawamura, Akio

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  4. Kazuki, Yasuhiro

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  5. Kitano, Kazuyoshi

    1. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo
      Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.115.064527
    2. Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma
      Yoshihiko Shimokawa, Katsunori Sasahara, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata, Noriaki Yoda and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1277-1283; DOI: https://doi.org/10.1124/dmd.115.064550

  6. Koyama, Noriyuki

    1. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo
      Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.115.064527
    2. Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma
      Yoshihiko Shimokawa, Katsunori Sasahara, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata, Noriaki Yoda and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1277-1283; DOI: https://doi.org/10.1124/dmd.115.064550

  7. Krugner-Higby, Lisa A.

    1. A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection
      Rebekah K. Franklin, Sarah A. Marcus, Adel M. Talaat, Butch K. KuKanich, Ruth Sullivan, Lisa A. Krugner-Higby and Timothy D. Heath
      Drug Metabolism and Disposition August 2015, 43 (8) 1236-1245; DOI: https://doi.org/10.1124/dmd.115.063602

  8. KuKanich, Butch K.

    1. A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection
      Rebekah K. Franklin, Sarah A. Marcus, Adel M. Talaat, Butch K. KuKanich, Ruth Sullivan, Lisa A. Krugner-Higby and Timothy D. Heath
      Drug Metabolism and Disposition August 2015, 43 (8) 1236-1245; DOI: https://doi.org/10.1124/dmd.115.063602

  9. Kurokawa, Takaya

    1. Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem Deacetylase
      Takaya Kurokawa, Tatsuki Fukami and Miki Nakajima
      Drug Metabolism and Disposition August 2015, 43 (8) 1218-1225; DOI: https://doi.org/10.1124/dmd.115.064089

L

  1. Lacy, Steven

    1. Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites
      Steven Lacy, Bih Hsu, Dale Miles, Dana Aftab, Ronghua Wang and Linh Nguyen
      Drug Metabolism and Disposition August 2015, 43 (8) 1190-1207; DOI: https://doi.org/10.1124/dmd.115.063610

  2. Lee, Eunyoung

    1. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner
      Eunyoung Lee, Zhexue Wu, Jong Cheol Shon and Kwang-Hyeon Liu
      Drug Metabolism and Disposition August 2015, 43 (8) 1250-1253; DOI: https://doi.org/10.1124/dmd.115.064345

  3. Leeder, J. Steven

    1. Variability in Expression of CYP3A5 in Human Fetal Liver
      Carrie A. Vyhlidal, Robin E. Pearce, Roger Gaedigk, Justina C. Calamia, Diana L. Shuster, Kenneth E. Thummel and J. Steven Leeder
      Drug Metabolism and Disposition August 2015, 43 (8) 1286-1293; DOI: https://doi.org/10.1124/dmd.115.064998

  4. Li, Chuan-Bao

    1. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59
      Da-Peng Dai, Shuang-Hu Wang, Chuan-Bao Li, Pei-Wu Geng, Jie Cai, Hao Wang, Guo-Xin Hu and Jian-Ping Cai
      Drug Metabolism and Disposition August 2015, 43 (8) 1246-1249; DOI: https://doi.org/10.1124/dmd.115.063412

  5. Li, Huiling

    1. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
      Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
      Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139

  6. Liu, Kwang-Hyeon

    1. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner
      Eunyoung Lee, Zhexue Wu, Jong Cheol Shon and Kwang-Hyeon Liu
      Drug Metabolism and Disposition August 2015, 43 (8) 1250-1253; DOI: https://doi.org/10.1124/dmd.115.064345

M

  1. Ma, Sijing

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  2. Maayah, Zaid H.

    1. Early Changes in Cytochrome P450s and Their Associated Arachidonic Acid Metabolites Play a Crucial Role in the Initiation of Cardiac Hypertrophy Induced by Isoproterenol
      Hassan N. Althurwi, Zaid H. Maayah, Osama H. Elshenawy and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition August 2015, 43 (8) 1254-1266; DOI: https://doi.org/10.1124/dmd.115.063776

  3. Marcus, Sarah A.

    1. A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection
      Rebekah K. Franklin, Sarah A. Marcus, Adel M. Talaat, Butch K. KuKanich, Ruth Sullivan, Lisa A. Krugner-Higby and Timothy D. Heath
      Drug Metabolism and Disposition August 2015, 43 (8) 1236-1245; DOI: https://doi.org/10.1124/dmd.115.063602

  4. Miles, Dale

    1. Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites
      Steven Lacy, Bih Hsu, Dale Miles, Dana Aftab, Ronghua Wang and Linh Nguyen
      Drug Metabolism and Disposition August 2015, 43 (8) 1190-1207; DOI: https://doi.org/10.1124/dmd.115.063610

N

  1. Nagar, Swati

    1. “Target-Site” Drug Metabolism and Transport
      Robert S. Foti, Rachel F. Tyndale, Kristine L. P. Garcia, Douglas H. Sweet, Swati Nagar, Satish Sharan and Dan A. Rock
      Drug Metabolism and Disposition August 2015, 43 (8) 1156-1168; DOI: https://doi.org/10.1124/dmd.115.064576

  2. Nakada, Naoyuki

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  3. Nakajima, Miki

    1. Characterization of Species Differences in Tissue Diltiazem Deacetylation Identifies Ces2a as a Rat-Specific Diltiazem Deacetylase
      Takaya Kurokawa, Tatsuki Fukami and Miki Nakajima
      Drug Metabolism and Disposition August 2015, 43 (8) 1218-1225; DOI: https://doi.org/10.1124/dmd.115.064089

  4. Nguyen, Linh

    1. Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites
      Steven Lacy, Bih Hsu, Dale Miles, Dana Aftab, Ronghua Wang and Linh Nguyen
      Drug Metabolism and Disposition August 2015, 43 (8) 1190-1207; DOI: https://doi.org/10.1124/dmd.115.063610

O

  1. Ohbuchi, Masato

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  2. Ohshita, Hiroki

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  3. Oshimura, Mitsuo

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

P

  1. Pearce, Robin E.

    1. Variability in Expression of CYP3A5 in Human Fetal Liver
      Carrie A. Vyhlidal, Robin E. Pearce, Roger Gaedigk, Justina C. Calamia, Diana L. Shuster, Kenneth E. Thummel and J. Steven Leeder
      Drug Metabolism and Disposition August 2015, 43 (8) 1286-1293; DOI: https://doi.org/10.1124/dmd.115.064998

  2. Prasad, Bhagwat

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

R

  1. Rock, Dan A.

    1. “Target-Site” Drug Metabolism and Transport
      Robert S. Foti, Rachel F. Tyndale, Kristine L. P. Garcia, Douglas H. Sweet, Swati Nagar, Satish Sharan and Dan A. Rock
      Drug Metabolism and Disposition August 2015, 43 (8) 1156-1168; DOI: https://doi.org/10.1124/dmd.115.064576

S

  1. Sasahara, Katsunori

    1. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo
      Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.115.064527
    2. Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma
      Yoshihiko Shimokawa, Katsunori Sasahara, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata, Noriaki Yoda and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1277-1283; DOI: https://doi.org/10.1124/dmd.115.064550

  2. Sato, Koya

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  3. Schuetz, Erin G.

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  4. Sharan, Satish

    1. “Target-Site” Drug Metabolism and Transport
      Robert S. Foti, Rachel F. Tyndale, Kristine L. P. Garcia, Douglas H. Sweet, Swati Nagar, Satish Sharan and Dan A. Rock
      Drug Metabolism and Disposition August 2015, 43 (8) 1156-1168; DOI: https://doi.org/10.1124/dmd.115.064576

  5. Shibata, Masakazu

    1. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo
      Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.115.064527
    2. Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma
      Yoshihiko Shimokawa, Katsunori Sasahara, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata, Noriaki Yoda and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1277-1283; DOI: https://doi.org/10.1124/dmd.115.064550

  6. Shimokawa, Yoshihiko

    1. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo
      Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.115.064527
    2. Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma
      Yoshihiko Shimokawa, Katsunori Sasahara, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata, Noriaki Yoda and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1277-1283; DOI: https://doi.org/10.1124/dmd.115.064550

  7. Shirasaka, Yoshiyuki

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  8. Shon, Jong Cheol

    1. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner
      Eunyoung Lee, Zhexue Wu, Jong Cheol Shon and Kwang-Hyeon Liu
      Drug Metabolism and Disposition August 2015, 43 (8) 1250-1253; DOI: https://doi.org/10.1124/dmd.115.064345

  9. Shuster, Diana L.

    1. Variability in Expression of CYP3A5 in Human Fetal Liver
      Carrie A. Vyhlidal, Robin E. Pearce, Roger Gaedigk, Justina C. Calamia, Diana L. Shuster, Kenneth E. Thummel and J. Steven Leeder
      Drug Metabolism and Disposition August 2015, 43 (8) 1286-1293; DOI: https://doi.org/10.1124/dmd.115.064998

  10. Sim, Sarah C.

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  11. Sullivan, Ruth

    1. A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection
      Rebekah K. Franklin, Sarah A. Marcus, Adel M. Talaat, Butch K. KuKanich, Ruth Sullivan, Lisa A. Krugner-Higby and Timothy D. Heath
      Drug Metabolism and Disposition August 2015, 43 (8) 1236-1245; DOI: https://doi.org/10.1124/dmd.115.063602

  12. Sweet, Douglas H.

    1. “Target-Site” Drug Metabolism and Transport
      Robert S. Foti, Rachel F. Tyndale, Kristine L. P. Garcia, Douglas H. Sweet, Swati Nagar, Satish Sharan and Dan A. Rock
      Drug Metabolism and Disposition August 2015, 43 (8) 1156-1168; DOI: https://doi.org/10.1124/dmd.115.064576

T

  1. Talaat, Adel M.

    1. A Novel Loading Method for Doxycycline Liposomes for Intracellular Drug Delivery: Characterization of In Vitro and In Vivo Release Kinetics and Efficacy in a J774A.1 Cell Line Model of Mycobacterium smegmatis Infection
      Rebekah K. Franklin, Sarah A. Marcus, Adel M. Talaat, Butch K. KuKanich, Ruth Sullivan, Lisa A. Krugner-Higby and Timothy D. Heath
      Drug Metabolism and Disposition August 2015, 43 (8) 1236-1245; DOI: https://doi.org/10.1124/dmd.115.063602

  2. Tateno, Chise

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

  3. Thummel, Kenneth E.

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428
    2. Variability in Expression of CYP3A5 in Human Fetal Liver
      Carrie A. Vyhlidal, Robin E. Pearce, Roger Gaedigk, Justina C. Calamia, Diana L. Shuster, Kenneth E. Thummel and J. Steven Leeder
      Drug Metabolism and Disposition August 2015, 43 (8) 1286-1293; DOI: https://doi.org/10.1124/dmd.115.064998

  4. Tyndale, Rachel F.

    1. “Target-Site” Drug Metabolism and Transport
      Robert S. Foti, Rachel F. Tyndale, Kristine L. P. Garcia, Douglas H. Sweet, Swati Nagar, Satish Sharan and Dan A. Rock
      Drug Metabolism and Disposition August 2015, 43 (8) 1156-1168; DOI: https://doi.org/10.1124/dmd.115.064576

U

  1. Umehara, Ken

    1. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo
      Katsunori Sasahara, Yoshihiko Shimokawa, Yukihiro Hirao, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.115.064527
    2. Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma
      Yoshihiko Shimokawa, Katsunori Sasahara, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata, Noriaki Yoda and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1277-1283; DOI: https://doi.org/10.1124/dmd.115.064550

  2. Usui, Takashi

    1. Development of Murine Cyp3a Knockout Chimeric Mice with Humanized Liver
      Kota Kato, Masato Ohbuchi, Satoko Hamamura, Hiroki Ohshita, Yasuhiro Kazuki, Mitsuo Oshimura, Koya Sato, Naoyuki Nakada, Akio Kawamura, Takashi Usui, Hidetaka Kamimura and Chise Tateno
      Drug Metabolism and Disposition August 2015, 43 (8) 1208-1217; DOI: https://doi.org/10.1124/dmd.115.063479

V

  1. Vyhlidal, Carrie A.

    1. Variability in Expression of CYP3A5 in Human Fetal Liver
      Carrie A. Vyhlidal, Robin E. Pearce, Roger Gaedigk, Justina C. Calamia, Diana L. Shuster, Kenneth E. Thummel and J. Steven Leeder
      Drug Metabolism and Disposition August 2015, 43 (8) 1286-1293; DOI: https://doi.org/10.1124/dmd.115.064998

W

  1. Wang, Guangji

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  2. Wang, Hao

    1. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59
      Da-Peng Dai, Shuang-Hu Wang, Chuan-Bao Li, Pei-Wu Geng, Jie Cai, Hao Wang, Guo-Xin Hu and Jian-Ping Cai
      Drug Metabolism and Disposition August 2015, 43 (8) 1246-1249; DOI: https://doi.org/10.1124/dmd.115.063412

  3. Wang, Hong

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  4. Wang, Lin

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  5. Wang, Ronghua

    1. Metabolism and Disposition of Cabozantinib in Healthy Male Volunteers and Pharmacologic Characterization of Its Major Metabolites
      Steven Lacy, Bih Hsu, Dale Miles, Dana Aftab, Ronghua Wang and Linh Nguyen
      Drug Metabolism and Disposition August 2015, 43 (8) 1190-1207; DOI: https://doi.org/10.1124/dmd.115.063610

  6. Wang, Shuang-Hu

    1. Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59
      Da-Peng Dai, Shuang-Hu Wang, Chuan-Bao Li, Pei-Wu Geng, Jie Cai, Hao Wang, Guo-Xin Hu and Jian-Ping Cai
      Drug Metabolism and Disposition August 2015, 43 (8) 1246-1249; DOI: https://doi.org/10.1124/dmd.115.063412

  7. Wang, Shuoguo

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  8. Wu, Gang

    1. The CYP2C19 Intron 2 Branch Point SNP is the Ancestral Polymorphism Contributing to the Poor Metabolizer Phenotype in Livers with CYP2C19*35 and CYP2C19*2 Alleles
      Amarjit S. Chaudhry, Bhagwat Prasad, Yoshiyuki Shirasaka, Alison Fohner, David Finkelstein, Yiping Fan, Shuoguo Wang, Gang Wu, Eleni Aklillu, Sarah C. Sim, Kenneth E. Thummel and Erin G. Schuetz
      Drug Metabolism and Disposition August 2015, 43 (8) 1226-1235; DOI: https://doi.org/10.1124/dmd.115.064428

  9. Wu, Mengqiu

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  10. Wu, Yuzheng

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  11. Wu, Zhexue

    1. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner
      Eunyoung Lee, Zhexue Wu, Jong Cheol Shon and Kwang-Hyeon Liu
      Drug Metabolism and Disposition August 2015, 43 (8) 1250-1253; DOI: https://doi.org/10.1124/dmd.115.064345

X

  1. Xie, Yang

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

Y

  1. Yan, Tingting

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  2. Yoda, Noriaki

    1. Metabolic Mechanism of Delamanid, a New Anti-Tuberculosis Drug, in Human Plasma
      Yoshihiko Shimokawa, Katsunori Sasahara, Noriyuki Koyama, Kazuyoshi Kitano, Masakazu Shibata, Noriaki Yoda and Ken Umehara
      Drug Metabolism and Disposition August 2015, 43 (8) 1277-1283; DOI: https://doi.org/10.1124/dmd.115.064550

Z

  1. Zeldin, Darryl C.

    1. Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation
      Joan P. Graves, Artiom Gruzdev, J. Alyce Bradbury, Laura M. DeGraff, Huiling Li, John S. House, Samantha L. Hoopes, Matthew L. Edin and Darryl C. Zeldin
      Drug Metabolism and Disposition August 2015, 43 (8) 1169-1180; DOI: https://doi.org/10.1124/dmd.115.064139

  2. Zhang, Jun

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  3. Zhao, Min

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800

  4. Zhu, Lin

    1. Ginsenosides Regulate PXR/NF-κB Signaling and Attenuate Dextran Sulfate Sodium–Induced Colitis
      Jun Zhang, Lijuan Cao, Hong Wang, Xuefang Cheng, Lin Wang, Lin Zhu, Tingting Yan, Yang Xie, Yuzheng Wu, Min Zhao, Sijing Ma, Mengqiu Wu, Guangji Wang and Haiping Hao
      Drug Metabolism and Disposition August 2015, 43 (8) 1181-1189; DOI: https://doi.org/10.1124/dmd.115.063800
Back to top

In this issue

Advertisement